Graduate Training in Stem Cell Biology and Regenerative Medicine
干细胞生物学和再生医学研究生培训
基本信息
- 批准号:10208896
- 负责人:
- 金额:$ 48.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY
This new T32 application seeks support for predoctoral training in the newly established doctoral degree
program in Stem Cell Biology and Regenerative Medicine (SCBRM) at Stanford University. The SCBRM
graduate program is the first new doctoral degree program at the School of Medicine in more than 20 years.
The program faculty span multiple schools and departments at Stanford and our primary goal is to train the
best scientists in this new discipline through a combination of basic stem cell biology and the role of stem cells
in the development, maintenance, and disease pathogenesis of human tissues and organs.
Over the last decade, fundamental discoveries in the biomedical and physical sciences have generated a
strong climate of expectation that discoveries should and will lead to new medical applications and novel
therapies. There is no greater expectation than that produced within the broad discipline of stem cell biology
and regenerative medicine, an established area of study that rests squarely on an unprecedented intersection
of disciplines. On the one hand, rapid advances in basic biology, genetics, material sciences, nanotechnology,
engineering, and physics are providing extraordinary new tools for harnessing stem cells in regenerative
medicine. On the other hand, rapid and continued growth of financial investment in translational medicine by
national, state, and private entities targets research dollars with an increasing focus on applied science.
Research in stem cell biology and regenerative medicine also raises ethical and legal concerns that are unique
in all of biological research; thus, this broad intersection of disciplines is producing a new breed of scientist,
one with skills that embrace biological and physical sciences, medicine, business, ethics and law.
In the following application we outline a novel predoctoral curriculum and training plan that provides a strong
foundation in developmental and cellular biology, genetics, and biochemistry. These intellectual strengths are
partnered with clinical science, bioengineering, business, ethics and law to produce a new generation of
scientist who is both motivated and capable of translating stem cell discoveries into new applications in
regenerative medicine.
项目总结
这一新的T32申请寻求对新设立的博士学位的博士前培训的支持
斯坦福大学干细胞生物学和再生医学(SCBRM)项目。SCBRM
研究生课程是医学院20多年来第一个新的博士学位课程。
该计划的教职员工横跨斯坦福大学的多个学院和系,我们的主要目标是培养
通过将基础干细胞生物学和干细胞的作用相结合,成为这一新学科中最优秀的科学家
在人体组织和器官的发育、维持和疾病发病机制中。
在过去的十年里,生物医学和物理科学的基础发现产生了
强烈的期待气氛,认为发现应该并将导致新的医学应用和创新
治疗。没有比在干细胞生物学的广泛学科中产生的期望更大的期望了。
和再生医学,这是一个建立在一个前所未有的交叉点上的既定研究领域
纪律的问题。一方面,基础生物学、遗传学、材料科学、纳米技术、
工程学和物理学正在为利用再生干细胞提供非凡的新工具
医药。另一方面,转化医学财政投资的快速和持续增长
国家、州和私人实体的目标是研究资金,越来越多地关注应用科学。
干细胞生物学和再生医学的研究也引发了独特的伦理和法律问题。
在所有的生物学研究中;因此,这种广泛的交叉学科正在产生一种新的科学家,
拥有涵盖生物和物理科学、医学、商业、伦理和法律的技能的人。
在下面的申请中,我们概述了一个新的博士前课程和培训计划,该计划提供了一个强有力的
发育和细胞生物学、遗传学和生物化学的基础。这些智力优势是
与临床科学、生物工程、商业、伦理和法律合作,产生新一代
既有动力又有能力将干细胞发现转化为新应用的科学家
再生医学。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Priming Human Repopulating Hematopoietic Stem and Progenitor Cells for Cas9/sgRNA Gene Targeting.
- DOI:10.1016/j.omtn.2018.04.017
- 发表时间:2018-09-07
- 期刊:
- 影响因子:0
- 作者:Charlesworth CT;Camarena J;Cromer MK;Vaidyanathan S;Bak RO;Carte JM;Potter J;Dever DP;Porteus MH
- 通讯作者:Porteus MH
Single amino acid mutations in the Saccharomyces cerevisiae rhomboid peptidase, Pcp1p, alter mitochondrial morphology.
酿酒酵母菱形肽酶 Pcp1p 中的单氨基酸突变会改变线粒体形态。
- DOI:10.1002/cbin.11219
- 发表时间:2020
- 期刊:
- 影响因子:3.9
- 作者:Huddleston,MaryElizabeth;Xiao,Ningyu;Both,AndriesPieter;Gordon,DonnaM
- 通讯作者:Gordon,DonnaM
CXCR2 inhibition in G-MDSCs enhances CD47 blockade for melanoma tumor cell clearance.
- DOI:10.1073/pnas.2318534121
- 发表时间:2024-01
- 期刊:
- 影响因子:11.1
- 作者:A. Banuelos;Allison Zhang;Hala Berouti;Michelle Baez;Leyla Yılmaz;Nardin Georgeos;Kristopher D Marjon-Kristop
- 通讯作者:A. Banuelos;Allison Zhang;Hala Berouti;Michelle Baez;Leyla Yılmaz;Nardin Georgeos;Kristopher D Marjon-Kristop
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IRVING L. WEISSMAN其他文献
IRVING L. WEISSMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IRVING L. WEISSMAN', 18)}}的其他基金
Programmed Cell Removal (PrCR) by Macrophages: recognition and phagocytosis of target cells
巨噬细胞的程序性细胞去除(PrCR):靶细胞的识别和吞噬作用
- 批准号:
10576906 - 财政年份:2020
- 资助金额:
$ 48.46万 - 项目类别:
Programmed Cell Removal (PrCR) by Macrophages: recognition and phagocytosis of target cells
巨噬细胞的程序性细胞去除(PrCR):靶细胞的识别和吞噬作用
- 批准号:
10092925 - 财政年份:2020
- 资助金额:
$ 48.46万 - 项目类别:
Programmed Cell Removal (PrCR) by Macrophages: recognition and phagocytosis of target cells
巨噬细胞的程序性细胞去除(PrCR):靶细胞的识别和吞噬作用
- 批准号:
9888242 - 财政年份:2020
- 资助金额:
$ 48.46万 - 项目类别:
Evolutionary Conserved Mechanisms of Neuronal Degeneration and Regeneration
神经元变性和再生的进化保守机制
- 批准号:
9979601 - 财政年份:2020
- 资助金额:
$ 48.46万 - 项目类别:
Programmed Cell Removal (PrCR) by Macrophages: recognition and phagocytosis of target cells
巨噬细胞的程序性细胞去除(PrCR):靶细胞的识别和吞噬作用
- 批准号:
10328484 - 财政年份:2020
- 资助金额:
$ 48.46万 - 项目类别:
Cellular and molecular analyses of hematopoietic stem cell [HSC] interactions with bone marrow niches to improve HSC engraftment for transplantation and tolerance induction
造血干细胞 [HSC] 与骨髓微环境相互作用的细胞和分子分析,以改善 HSC 植入移植和耐受诱导
- 批准号:
9753220 - 财政年份:2018
- 资助金额:
$ 48.46万 - 项目类别:
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
干细胞生物学、癌症干细胞生物学和癌症免疫治疗
- 批准号:
10247050 - 财政年份:2017
- 资助金额:
$ 48.46万 - 项目类别:
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
干细胞生物学、癌症干细胞生物学和癌症免疫治疗
- 批准号:
10458105 - 财政年份:2017
- 资助金额:
$ 48.46万 - 项目类别:
A search for genes that regulate allogeneic stem cell competition
寻找调节同种异体干细胞竞争的基因
- 批准号:
8627187 - 财政年份:2012
- 资助金额:
$ 48.46万 - 项目类别:
相似海外基金
A postdoctoral training program for impactful careers in stem cell biology
干细胞生物学领域有影响力的职业博士后培训计划
- 批准号:
10410891 - 财政年份:2022
- 资助金额:
$ 48.46万 - 项目类别:
A postdoctoral training program for impactful careers in stem cell biology
干细胞生物学领域有影响力的职业博士后培训计划
- 批准号:
10592329 - 财政年份:2022
- 资助金额:
$ 48.46万 - 项目类别:
Training in Pediatric Nonmalignant Hematology and Stem Cell Biology
儿科非恶性血液学和干细胞生物学培训
- 批准号:
10382278 - 财政年份:2020
- 资助金额:
$ 48.46万 - 项目类别:
Graduate Training in Stem Cell Biology and Regenerative Medicine
干细胞生物学和再生医学研究生培训
- 批准号:
9278892 - 财政年份:2017
- 资助金额:
$ 48.46万 - 项目类别:
Training Program in Developmental and Stem Cell Biology
发育和干细胞生物学培训计划
- 批准号:
9260703 - 财政年份:2015
- 资助金额:
$ 48.46万 - 项目类别:
Training in Pediatric Nonmalignant Hematology and Stem Cell Biology
儿科非恶性血液学和干细胞生物学培训
- 批准号:
9265456 - 财政年份:2014
- 资助金额:
$ 48.46万 - 项目类别:
Training in Pediatric Nonmalignant Hematology and Stem Cell Biology
儿科非恶性血液学和干细胞生物学培训
- 批准号:
8667356 - 财政年份:2014
- 资助金额:
$ 48.46万 - 项目类别: